First Wave BioPharma Inc (FWBI) is down 6.89% Friday In Premarket Trading

Friday, March 15, 2024 06:45 AM | InvestorsObserver Analysts

Mentioned in this article

First Wave BioPharma Inc (FWBI) is down Friday morning, with the stock losing -6.89% in pre-market trading to 5. FWBI's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, FWBI ranks higher than 0% of stocks. First Wave BioPharma Inc has risen 7.62% over the past month, closing at $5.23 on February 16. During this period of time, the stock fell as low as $4.96 and as high as $9.35. FWBI has an average analyst recommendation of Strong Buy. The company has an average price target of $40.00.

FWBI has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on FWBI!
First Wave BioPharma Inc has a Long-Term Technical rank of 27. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 73% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, FWBI ranks better than 74% of stocks.

Important Dates for Investors in FWBI:

-First Wave BioPharma Inc is set to release earnings on 2024-03-18. Over the last 12 months, the company has reported EPS of $1131.40. -We do not have a set dividend date for First Wave BioPharma Inc at this time. Click Here To Get The Full Report on First Wave BioPharma Inc (FWBI)

Share this article: